These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 16029294

  • 21. ThinPrep pap test: a platform for gynecological diagnosis.
    Scimia M.
    Adv Clin Path; 2001 Oct; 5(4):183-4. PubMed ID: 17582941
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ.
    J Natl Cancer Inst; 2008 Sep 17; 100(18):1290-300. PubMed ID: 18780864
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Re: An alternative cost-effectiveness analysis of ThinPrep in the Australian setting.
    Llewellyn H.
    Aust N Z J Obstet Gynaecol; 2006 Feb 17; 46(1):67. PubMed ID: 16441702
    [No Abstract] [Full Text] [Related]

  • 32. The ultimate goal? It depends.
    Brown E.
    Physician Exec; 1996 Oct 17; 22(10):50-2. PubMed ID: 10162496
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Melamed MR, Hutchinson ML, Kaufman EA, Schechter CB, Garner D, Kobler TP, Krieger PA, Reith A, Schenck U.
    Acta Cytol; 1998 Oct 17; 42(1):69-75. PubMed ID: 9479325
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Levin CE, Sellors JW.
    Cancer; 2002 Apr 15; 94(8):2312-4; author reply 2314-6. PubMed ID: 12001136
    [No Abstract] [Full Text] [Related]

  • 36. Expensive care - a rationale for economic evaluations in intensive care.
    Higgins AM, Pettila V, Bellomo R, Harris AH, Nichol AD, Morrison SS.
    Crit Care Resusc; 2010 Mar 15; 12(1):62-6. PubMed ID: 20196716
    [Abstract] [Full Text] [Related]

  • 37. The cost-effectiveness of cervical cancer screening for low-income elderly women.
    Mandelblatt JS, Fahs MC.
    JAMA; 2010 Mar 15; 259(16):2409-13. PubMed ID: 3127608
    [Abstract] [Full Text] [Related]

  • 38. [Cost-effectiveness of a cervical cancer screening programme in the Algarve region, Portugal].
    Novoa Vázquez RM.
    Rev Esp Salud Publica; 2004 Mar 15; 78(3):341-53. PubMed ID: 15293955
    [Abstract] [Full Text] [Related]

  • 39. Cost analysis of PAPNET-assisted vs. conventional Pap smear evaluation in primary screening of cervical smears.
    Meerding WJ, Doornewaard H, van Ballegooijen M, Bos A, van der Graaf Y, van den Tweel JG, van der Schouw YT, Habbema JD.
    Acta Cytol; 2001 Mar 15; 45(1):28-35. PubMed ID: 11213501
    [Abstract] [Full Text] [Related]

  • 40. Has the ThinPrep method of cervical screening maintained its improvement over conventional smears in terms of specimen adequacy?
    Treacy A, Reynolds J, Kay EW, Leader M, Grace A.
    Diagn Cytopathol; 2009 Apr 15; 37(4):239-40. PubMed ID: 19217033
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.